138 related articles for article (PubMed ID: 2523884)
1. Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
Stratford IJ; Hickson ID; Robson CN; Stephens M
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1307-10. PubMed ID: 2523884
[TBL] [Abstract][Full Text] [Related]
2. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
Austen KR; Jenner TJ; O'Neill P; Fielden EM
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
Walling JM; Stratford IJ; Adams GE; Silver AR; Ahmed I; Jenkins TC; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
[TBL] [Abstract][Full Text] [Related]
4. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
[TBL] [Abstract][Full Text] [Related]
5. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
[TBL] [Abstract][Full Text] [Related]
6. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
[TBL] [Abstract][Full Text] [Related]
7. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
[TBL] [Abstract][Full Text] [Related]
8. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
[TBL] [Abstract][Full Text] [Related]
9. The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: quantitative differences found using the radiation sensitizing agent misonidazole or oxygen.
Koch CJ; Stobbe CC; Bump EA
Radiat Res; 1984 Apr; 98(1):141-53. PubMed ID: 6718689
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of Chinese hamster ovary cells to melphalan by etanidazole under intermittent hypoxia.
Bump EA; Coleman CN; Cerce BA; McGinnis DJ
Int J Radiat Oncol Biol Phys; 1992; 22(4):731-5. PubMed ID: 1531977
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
DeGraff WG; Russo A; Gamson J; Mitchell JB
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
[TBL] [Abstract][Full Text] [Related]
12. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
Astor M; Hall EJ
Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
[TBL] [Abstract][Full Text] [Related]
13. Studies on the toxicity of RSU-1069.
Whitmore GF; Gulyas S
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1219-22. PubMed ID: 3755716
[TBL] [Abstract][Full Text] [Related]
14. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
Palcic B; Faddegon B; Skarsgard LD
Radiat Res; 1984 Nov; 100(2):340-7. PubMed ID: 6494445
[TBL] [Abstract][Full Text] [Related]
15. The interaction of misonidazole with radiation, chemotherapeutic agents, or heat: a preliminary report.
Stratford IJ; Adams GE; Horsman MR; Kandaiya S; Rajaratnam S; Smith E; Williamson C
Cancer Clin Trials; 1980; 3(3):231-6. PubMed ID: 7192182
[TBL] [Abstract][Full Text] [Related]
16. Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
Roizin-Towle L; Pirro JP; Hall EJ
Radiat Res; 1990 Oct; 124(1 Suppl):S50-5. PubMed ID: 2236511
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of some bioreducible 2-nitroimidazoles: comparison of in vitro cytotoxicity and ability to induce DNA strand breakage.
O'Neill P; Jenkins TC; Stratford IJ; Silver AR; Ahmed I; McNeil SS; Fielden EM; Adams GE
Anticancer Drug Des; 1987 Apr; 1(4):271-80. PubMed ID: 3450299
[TBL] [Abstract][Full Text] [Related]
18. A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines.
Suto MJ; Stier MA; Werbel LM; Arundel-Suto CM; Leopold WR; Elliott WE; Sebolt-Leopold JS
J Med Chem; 1991 Aug; 34(8):2484-8. PubMed ID: 1875345
[TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
[TBL] [Abstract][Full Text] [Related]
20. Increased radiosensitivity of aerobic mammalian cells following pre-incubation with misonidazole in hypoxia.
Michaels HB
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1271-4. PubMed ID: 6469749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
